Piperdine-amino-benzimidazole derivatives as inhibitors of...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

10596519

ABSTRACT:
The present invention concerns piperidine-amino-benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formulatheir prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms wherein Q is C1−6alkyl optionally substituted with trifluoromethyl, C3-7cycloalkyl, Ar2, hydroxy, C1−4alkoxy, C1−4alkylthio, Ar2-oxy-, Ar2-thio-, Ar2(CH2)noxy, Ar2(CH2)nthio, hydroxycarbonyl, aminocarbonyl, C1−4alkyl-carbonyl, Ar2carbonyl, C1−4alkoxycarbonyl, Ar2(CH2)ncarbonyl, aminocarbonyloxy, C1−4alkylcarbonyloxy, Ar2carbonyloxy, Ar2(CH2)ncarbonyloxy, C1−4alkoxy-carbonyl(CH2)noxy, mono- or di(C1−4alkyl)aminocarbonyl, mono- or di(C1−4alkyl)-aminocarbonyloxy, aminosulfonyl, mono- or di(C1−4alkyl)aminosulfonyl or a heterocycles selected from the group consisting of pyrrolidinyl, pyrrolyl, dihydropyrrolyl, imidazolyl, triazolyl, piperidinyl, homopiperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, pyridyl and tetrahydropyridyl, wherein each of said heterocycle may optionally be substituted with oxo or C1−6alkyl; G is a direct bond or optionally substituted C1-10alkanediyl; R1is Ar1or a monocyclic or bicyclic heterocycle; one of R2aand R3ais C1−6alkyl and the other one of R2aand R3ais hydrogen; in case R2ais different from hydrogen then R2bis hydrogen or C1−6alkyl, and R3bis hydrogen; in case R3ais different from hydrogen then R3bis hydrogen or C1−6alkyl, and R2bis hydrogen; t is 1, 2 or 3; Ar1is phenyl or substituted phenyl; and Ar2is phenyl or substituted phenyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

REFERENCES:
patent: 4219559 (1980-08-01), Janssens et al.
patent: 0005318 (1979-11-01), None
patent: 0099139 (1983-06-01), None
patent: 0145037 (1984-09-01), None
patent: WO 92/01687 (1992-02-01), None
patent: WO 01/00611 (2001-01-01), None
patent: WO-01-00611 (2001-01-01), None
patent: WO 01/00612 (2001-01-01), None
patent: WO 01/00615 (2001-01-01), None
Janssens et al. Journal of Medicinal Chemistry, 1985, 28, 1934-1943; p. 1939, Example 87.
International Search Report, International Application No. PCT/EP2004/053606, Date of Mailing of International Search Report, Apr. 15, 2005.
Benet, et al., “Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, and Elimination.”,Goodman and Gilman's The Pharmacological Basis of Therapeutics, Eighth Edition, pp. 13-20, McGraw-Hill Inc.
Janssens, F. et al., “New Antihistamine N-Heterocyclic 4-Piperidinamines.2. Synthesis and Antihistaminic Activity of 1-(4-Fluorophenyl)-1H-Benzimidazol-2-Amines.”,Journal of Medicinal Chemistry, Dec. 1985, vol. 28, No. 121, pp. 1934-1943, American Chemical Society, Washington, US, XP000881979.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Piperdine-amino-benzimidazole derivatives as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperdine-amino-benzimidazole derivatives as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperdine-amino-benzimidazole derivatives as inhibitors of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3924142

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.